Seeka
Seeka is a New Zealand company concentrating on whole of
production kiwifruit industry in New Zealand.
I first became interested in the stock when the stock price hit $1.00 and the book value was $3.99. The stock is currently selling at an EV/EBITDA ratio of 1.42.
I purchased some stock at $0.92 but then quickly sold at
$0.85 when I realised that my order filled part of a director’s sale
order that made me think about this a second time. Looking on past filings, I see
that this director is the second largest insider holder and has been selling
stock since a biological pest was discovered in New Zealand that could (and has
already begun to) destroy the kiwifruit industry. The price is now $0.81, and given the book
value, I’m investigating at what price I would re purchase this company.
What does Seeka do?
Seeka is basically a vertically-integrated kiwifruit producer. It leases orchards and grows kiwifruit (and manages orchards for others), harvests the fruit, processes it, and packs it ready for sale.
Seeka’s half-year report is sobering reading. The conclusion of the Chairman’s address says
it all:
This remains a
testing time for the industry and Seeka. The pressure of the Psa-V outbreak
alongside a challenging harvest and grower uncertainty has again demonstrated
how Seeka’s dedicated leadership, dedicated people and its strategy, position
the company well to deliver the best outcome to growers and shareholders in the
current environment.
Below is a snap of their balance sheet as at 30 June 2012. I draw your attention to three items. The first is the bottom line. Net assets come in at $59 million. That is as compared with a market cap (today)
of $11.7 million. Net assets are
currently 5 times market cap. The second
item is one item in current assets – trade and other receivables. It’s a massive $28 million. Its
receivables are higher than its market cap.
The other large asset (non-current) on its balance sheet is property,
plant and equipment, at $69 million.
Check the arows, they point to matters I find of interest |
Note 9 (on Trade and other receivables) states:
Note 9. Related party transactions
Seeka Growers Limited
In the normal
course of business the Group undertakes transactions with Seeka Growers
Limited, a related party which administers all post harvest operations and
revenues from the sale of kiwifruit on behalf of growers with whom it holds a contract.
In the current period the Group received $50,318,169 (2011: $51,195,190) for
the provision of post harvest and orchard management services to Seeka Growers
Limited. At balance date, a significant portion of receivables are due from
Seeka Growers Limited. These receivables are funded by future fruit payments
from Zespri Group Limited to Seeka Growers Limited.
I find this a pretty odd
note. Basically, Seeka gets money from Seeka Growers Limited (a
related party). Seeka does all the post
harvest work for Seeka Growers Limited, who have not yet paid for the work. That all makes sense I guess. It’s the last sentence that’s a bit
weird. “These receivables are funded by
future fruit payments from Zespri Group Limited to Seeka Growers Limited”.
So basically, Seeka Growers Limited can’t pay
Seeka until Zespri pays Seeka Growers.
Zespri is a legislated
co-operative of kiwifruit growers.
Basically, the way I read that note is that Seeka gets paid if Seeka Growers get paid. Seeka Growers get paid if it can sell fruit to Zespri in the future. But what if
the Kiwifruit industry is finished? Zespri might not be able to pay Seeka
Growers, and Seeka Growers might not be able to pay Seeka.
Psa
Zespri’s annual report (year
ended 31 March 2012 - available on their website) states that 30% of New
Zealand kiwifruit orchards have some Psa (Pseudomonas syringae pv. actinidiae)
infection.
This news article from September 4 states that nearly 50 per cent of kiwifruit crops in New
Zealand are on an infected orchard.
A 13 August market update from Seeka contained the following ominous line:
Seeka continues
to caution the market that the outbreak which is now in its second year has the
potential to seriously impact on future earnings for the Company.
The question is, let’s say future
earnings for Seeka collapse, what happens to the company? Clearly if the Kiwifruit industry in New
Zealand halves (not out of the question now that Psa is here – many orchardists
may switch to another crop that doesn’t get hit by Psa), the assets that Seeka
have won’t be worth anywhere near book value.
Seeka has specialised factories
for processing and packing kiwifruit.
Now of course those assets will have some value to another fruit
company, or another kiwifruit factory out of New Zealand.
But I imagine that shipping a
factory from New Zealand to somewhere else that grows kiwifruit reduces the
book value and sale price of that factory substantially. Seeka says that its land and building assets
were revalued at 31 December 2011 taking into account the Psa discovery. When $69 million of assets is in “property,
plant and equipment”, any further reduction to take into account the wider
spread of Psa seriously erodes the $59 million net asset base.
A further aspect I haven't touched on (and won't in any detail) is that assuming that the kiwifruit industry isn't destroyed, merely decimated (in the original sense of the term - ie, cut by 10%), the excess capacity for processing and packing kiwifruit will drive the revenues from these activities down so that Seeka's margins (if they exist) will be suppressed indefinitely as the industry consolidates.
Seeka’s annual report for the
year ended 31 December 2001 records revalued land (after initial Psa discovery)
at $2.8 million. It records buildings at
$37 million, and plant and equipment at $31 million. If land was worth $37 million vs a building
of $2.8 million, then buying now might be a good move – the land is likely to
be far less affected by changes in what can be grown on it, than a building or
plant equipment can by what can be processed through it. The land is fertile and can grow stuff; the
buildings/plant are all geared for a particular crop.
But don’t rely on my opinion:
director Stuart Burns has reduced his position in the company since 30 November
2011 to 150,000 shares from 300,000.
Finding that makes me happy to have exited the position (but kicking
myself for ever initiating it).
I started this exercise asking at
what price would I buy this company.
After undertaking this exercise, I can say that I won’t touch this
company at any price. There may be value
here, but to see that you’d have to have stepped foot inside a kiwifruit
processing factory and have an idea of how much you’d be able to get for the
stuff in a liquidation. Maybe a Psa resistant
strain of kiwifruit will be found tomorrow – but I know as much about kiwifruit
disease epidemiology as I do about kiwifruit factories so have no advantage
there.
No comments:
Post a Comment